基本信息
浏览量:408
职业迁徙
个人简介
Jiang pioneered the molecular understanding, design and development of functional zwitterionic materials. Since the early 2000s, his group has proposed the concept of super-hydrophilic zwitterionic materials, provided a molecular-level understanding of non-fouling mechanisms and developed several new classes of zwitterionic materials, including poly(carboxybetaine), poly(sulfobetaine), poly(trimethylamine N-oxide), poly(zwitterionic phosphatidylserine), and glutamic acid (E) and lysine (K)-containing poly(peptides). His group has demonstrated no capsule formation upon subcutaneous implantation in mice for one year, expansion of hematopoietic stem and progenitor cells (HSPCs) without differentiation, no anti-coagulants needed for artificial lungs in sheep, no antibodies generated against zwitterionic polymers, and environmentally benign marine coatings. These highly biocompatible zwitterionic materials are excellent alternatives to widely used poly(ethylene glycol) (PEG) counterparts as PEG immunogenicity was found in COVID-19 vaccines. He co-founded three companies – ZWI Therapeutics, Taproot Medical and Imperion Coatings based on over 50 awarded patents on zwitterionic technologies. Largely resulting from his work, zwitterionic materials have been widely adopted for biomedical and engineering applications.
At Cornell, his group aims to (a) integrate immunology into his biomaterials and drug delivery research programs; (b) translate his biomaterials and drug delivery technologies into medical and engineering practice. Currently, his group performs both basic and applied research integrating science, engineering and medicine, particularly in two areas: (i) Biomaterials for regenerative and precision medicine: His group is developing highly biocompatible and immunomodulating materials for the controlled culture of iPSCs and cancer organoids along with capsule-free long-term implants and anticoagulant-free blood-contacting devices in vivo. Similar materials have been applied to anti-fouling marine coatings; (ii) Drug delivery for cancer vaccines & neurological diseases: His group is developing low-immunogenic and targeted viral and non-viral carriers for the delivery of mRNAs, DNAs, proteins and small molecules for cancer and infectious disease vaccines along with the treatments of several diseases such as cancer, neurological diseases and diabetes. His group has close collaborations with researchers at Weill Cornell Medicine, Cornell College of Veterinary Medicine, and several other departments at Cornell and beyond.
At Cornell, his group aims to (a) integrate immunology into his biomaterials and drug delivery research programs; (b) translate his biomaterials and drug delivery technologies into medical and engineering practice. Currently, his group performs both basic and applied research integrating science, engineering and medicine, particularly in two areas: (i) Biomaterials for regenerative and precision medicine: His group is developing highly biocompatible and immunomodulating materials for the controlled culture of iPSCs and cancer organoids along with capsule-free long-term implants and anticoagulant-free blood-contacting devices in vivo. Similar materials have been applied to anti-fouling marine coatings; (ii) Drug delivery for cancer vaccines & neurological diseases: His group is developing low-immunogenic and targeted viral and non-viral carriers for the delivery of mRNAs, DNAs, proteins and small molecules for cancer and infectious disease vaccines along with the treatments of several diseases such as cancer, neurological diseases and diabetes. His group has close collaborations with researchers at Weill Cornell Medicine, Cornell College of Veterinary Medicine, and several other departments at Cornell and beyond.
研究兴趣
论文共 393 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Wenchao Gu,Sijin Luozhong, Simian Cai, Ketaki Londhe, Nadine Elkasri,Robert Hawkins,Zhefan Yuan, Kai Su-Greene, Yujie Yin, Margaret Cruz, Yu-Wei Chang,Patrick McMullen,
Chemical Scienceno. 23 (2023): 6375-6382
引用0浏览0引用
0
0
CHEMICAL SCIENCEno. 23 (2023): 6375-6382
引用0浏览0WOS引用
0
0
Chemical scienceno. 27 (2023): 7500-7511
Jingyuan Deng,Sean Bailey, Ruiwen Ai, Anthony Delmonico,Gregory Denbeaux,Shaoyi Jiang,Christopher K. Ober
Wenchao Gu,Sijin Luozhong, Ketaki Londhe,Simian Cai, Nadine Elkasri,Robert Hawkins,Zhefan Yuan, Kai Su-Greene, Margaret Cruz, Yu-Wei Chang,Patrick McMullen,Chunyan Wu,
biorxiv(2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn